Skip to main content
Fig. 3 | Immunity & Ageing

Fig. 3

From: Kinetics of COVID-19 mRNA primary and booster vaccine-associated neutralizing activity against SARS-CoV-2 variants of concern in long-term care facility residents: a prospective longitudinal study in Japan

Fig. 3

Correlation between IgG (S-RBD) and neutralizing activity. We assessed the correlation between antibodies to the receptor-binding domain of the S1 subunit of the viral spike protein [IgG (S-RBD)] and neutralizing activity against the wild-type virus and the Delta and Omicron variants. The left, middle, and right columns show correlations between neutralizing activity against the wild-type virus and the Delta and Omicron variants, respectively, and the IgG (S-RBD) levels. The upper, middle, and lower rows show the correlations in periods 1, 3, and 4, respectively. The neutralizing activity was plotted as zero when the recordings were negative

Back to article page